Lezárult
Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma
NCT01553149· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
NCT01602666· 2. fázis· Children's Oncology Group· Forrás
Lezárult
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
NCT02883049· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission
NCT01503632· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
NCT01371981· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
NCT01231906· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma
NCT01190930· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma
NCT01096368· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer
NCT00980460· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
NCT00945009· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System
NCT00653068· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00557193· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma
NCT00336024· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
NCT00379340· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
NCT00408005· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
NCT00352534· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease
NCT00107198· 2. fázis· Children's Oncology Group· Forrás
Lezárult
Study of Kidney Tumors in Younger Patients
NCT00898365· Children's Oncology Group· Forrás
Lezárult
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
NCT00085735· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors
NCT00082745· Children's Oncology Group· Forrás
Lezárult
Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma
NCT00026312· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
NCT00904241· Children's Oncology Group· Forrás